Kontafarma China Holdings Limited

SEHK:1312 Voorraadrapport

Marktkapitalisatie: HK$190.0m

Kontafarma China Holdings Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Feifei Wang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijnless than a year
Gemiddelde ambtstermijn bestuurless than a year

Recente managementupdates

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

Recent updates

Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Oct 09
Kontafarma China Holdings Limited's (HKG:1312) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Is Kontafarma China Holdings (HKG:1312) Weighed On By Its Debt Load?

Sep 04
Is Kontafarma China Holdings (HKG:1312) Weighed On By Its Debt Load?

Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

May 31
Here's Why Kontafarma China Holdings Limited's (HKG:1312) CEO Compensation Is The Least Of Shareholders Concerns

There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

May 24
There's No Escaping Kontafarma China Holdings Limited's (HKG:1312) Muted Revenues Despite A 61% Share Price Rise

Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Dec 28
Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Sep 01
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Dec 29
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?

Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Sep 15
Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?

Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Apr 20
Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?

Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Nov 04
Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?

Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

Feb 18
Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares

These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

Dec 07
These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively

CEO

Feifei Wang

less than a year

Tenure

Mr. Feifei Wang is Executive Chairman & President of Kontafarma China Holdings Limited from June 7, 2024.


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Feifei Wang
Executive Chairman & Presidentless than a yeargeen gegevensgeen gegevens
Zixiu Guo
Financial Controller & Executive Directorless than a yeargeen gegevensgeen gegevens
Jie Zhang
Chief Operating Officer4.2yrsgeen gegevensgeen gegevens
Linna Qiao
VP & Executive Directorless than a yeargeen gegevensgeen gegevens
Jiankun Liu
Executive Directorless than a yeargeen gegevensgeen gegevens
Lok Tung Chan
Company Secretaryless than a yeargeen gegevensgeen gegevens

0.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van 1312 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.4 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Feifei Wang
Executive Chairman & Presidentless than a yeargeen gegevensgeen gegevens
Zixiu Guo
Financial Controller & Executive Directorless than a yeargeen gegevensgeen gegevens
Linna Qiao
VP & Executive Directorless than a yeargeen gegevensgeen gegevens
Jiankun Liu
Executive Directorless than a yeargeen gegevensgeen gegevens
Lai Wah Tang
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Yu Huang
Non-Executive Director10.7yrsHK$1.67mgeen gegevens
Ho Ming Ho
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Xiaomin Yao
Independent Non-Executive Directorless than a yeargeen gegevensgeen gegevens

0.4yrs

Gemiddelde duur

57.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1312 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.4 jaar), wat duidt op een nieuw bestuur.